Literature DB >> 22086685

Microsatellite instability in young patients with sporadic colorectal adenomas.

Sung Keun Park1, Dong Il Park, Seung Ha Park, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Min-Kyung Kim, Jeong Seon Ji, Seon Ja Park, Dong Soo Han.   

Abstract

BACKGROUND/AIMS: This study was designed to determine the prevalence of microsatellite instability (MSI) among colorectal adenomas detected in patients ≤ 40 years of age and to compare the prevalence of MSI in young (≤ 40 years) and older (>40 years) patients with colorectal adenomas. Additionally, we attempted to identify the underlying cause of MSI in these patients.
METHODOLOGY: We prospectively tested for the presence of MSI using five NCI markers in samples from the two patient groups. The frequency of MSI was compared and the underlying causes of MSI were determined by methylation specific PCR and germ-line mutation analysis for mismatch repair genes.
RESULTS: The frequency of MSI was higher in the ≤ 40 group than the >40 group (31.4% and 6.4%, respectively, p=0.0004). The MSI-high pattern was also more prevalent in the ≤ 40 group than the >40 group (15.7% and 2.5%, respectively, p=0.014). The hypermethylated hMLH1 gene was demonstrated in 7/8 (87.5%) patients with MSI-high in the ≤ 40 group and in 1/2 (50.0%) patients with MSI-high in the >40 group. No study subject showed a germline mutation of hMLH1 or hMSH2.
CONCLUSIONS: MSI-high was more frequent in young (≤ 40 years) patients with colorectal adenoma than in older (>40 years) patients. Hypermethylation of the hMLH1 gene appears to be an important cause of MSI-high in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086685     DOI: 10.5754/hge09608

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

1.  The correlation between DNA mismatch repair status and the clinicopathological and molecular features of Chinese sporadic colorectal cancer.

Authors:  Cong Li; Fangqi Liu; Dan Huang; Yuchen Wu; Zhimin Wang; Ye Xu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.